Ventricular constraint in severe heart failure halts decline in cardiovascular function associated with experimental dilated cardiomyopathy

Annals of Thoracic Surgery

Volumn 76, Issue 1, 2003, Pages 141-147

  Raman, Jai S ^a   Byrne, Melissa J ^b   Power, John M ^b   Alferness, Clif A ^b  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC SUPPORT DEVICE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; DEVICE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; HEART DILATATION; HEART FAILURE; HEART VENTRICLE FUNCTION; HEART VENTRICLE PACING; MITRAL VALVE REGURGITATION; NONHUMAN; PRIORITY JOURNAL; SHEEP; STATISTICAL SIGNIFICANCE; STERNOTOMY; TREADMILL EXERCISE;

ANIMALS; BIOPSY, NEEDLE; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; EXERCISE TEST; HEART FUNCTION TESTS; HEMODYNAMIC PROCESSES; IMMUNOHISTOCHEMISTRY; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SHEEP; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0038676379     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(03)00185-1     Document Type: Article

References (13)

1. Power JM, Raman J, Dornom A, et al. Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy. Cardiovasc Res 1999;44:549-55.
2. Chaudhry PA, Mishima T, Sharov VG, et al. Passive epicardial containment prevents ventricular remodeling in heart failure. Ann Thorac Surg 2000;70:1275-80.
3. Magovern JA, Furnary PA, Christlieb IY, Kao RL, Partk SB, Magovern GJ. Indications and risk analysis for clinical cardiomyoplasty. Semin Thorac Cardiovasc Surg 1991;3:145-8.
4. Kass DA, Baughman KL, Pak PH, et al. Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation 1995;91:2314-8.
5. Raman JS, Power JM, Buxton BF, Alferness CA, Hare D. Ventricular containment as an adjunctive procedure in ischemic cardiomyopathy: early results. Ann Thorac Surg 2000;70:1124-6.
6. Konertz WF, Shapland JE, Hotz H, et al. Passive containment and reverse remodeling by a novel textile cardiac support device. Circulation 2001;104(Suppl 1):270-5.
7. Howard RJ, Stopps TP, Moe GW, Gotleib A, Armstrong PW. Recovery from heart failure: structural and functional analysis in a canine model. Can J Physiol Pharmacol 1988;66:1505-12.
8. Konertz WS, Dushe S, Braun JP, et al. Safety and feasibility of a cardiac support device. J Card Surg 2001;16:113-7.
9. Sabbah HN, Kleber FX, Konertz WF. Efficacy trends of the acorn cardiac support device in patients with heart failure: a one year follow-up. J Heart Lung Transplant 2001;20:217.
10. Saavedra WF, Tunin RS, Paolocci N, Mishima T, et al. Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure. J Am Coll Cardiol 2002;39:2069-76.
11. Sabbah HN, Maltsev VA, Chaudhry PA, Mishima T, Undrovinas AI. Contractile function of cardiomyocytes isolated from dogs with heart failure is enhanced after chronic therapy with passive ventricular constraint using the Acorn cardiac support device. Circulation 1999;100(Suppl 2):439.
12. Sabbah HN, Gupta RC, Sharov VG, et al. Prevention of progressive left ventricular dilation with the Acorn Cardiac Support Device down regulates stretch-mediated p21ras, attenuates myocyte hypertrophy and improves sacroplasmic reticulum calcium channel cycling in dogs with heart failure. Circulation 2000;104(Suppl 2):556.
13. Carpentier A, Chachques JC. Clinical dynamic cardiomyoplasty: method and outcome. Semin Thorac Cardiovasc Surg 1991;3:136-9.